期刊文献+

多柔吡星脂质体过敏致低血压性休克

原文传递
导出
摘要 1临床资料 患者,女,62岁,因左乳癌术后1月余入院。患者于2016年12月7号因"发现左乳肿物3年,疼痛5 d"就诊于我院,入院后完善相关检查,彩超示:左乳多发结节,双侧腋窝未见明显增大淋巴结。于2016年12月8日行全麻下左乳癌改良根治术,术中冰冻(左乳外上)乳腺浸润性癌,(左乳内上)乳腺导管上皮高度增生伴不典型增生及乳头状瘤。
作者 李立 赵静
出处 《中国医院药学杂志》 CAS 北大核心 2018年第14期1566-1566,共1页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献1

二级参考文献18

  • 1陈腾,茹小鹏,顾珊智,韩卫,贾晓俤,高雅,张秦初.药物不良事件及其法医学鉴定[J].法医学杂志,2007,23(1):26-29. 被引量:5
  • 2SLINGEKLAND M, GUCHELAAR HJ, GELDERBLOM H. Li-posomal drug formulations in cancer therapy : 15 years along theroad [ J ]. Drug Discov Today ,2012, 17(3-4): 160 -166.
  • 3ALLEN TM, HANSEN CB,DEMENEZES DEL. Pharmacokinet-ics of long cir-culating liposomes[ J]. Adv Drug Deliv Rev, 1995,16(2 - 3 ) : 267 -284.
  • 4NORTHFELT DW, MARTIN FJ,WORKING .,et al. Doxorubi-cin encapsu-lated in liposomes containing surface bound polyethy-lene glycol : plarmackinetics,tumor localization and safety in pa-tients with AIDS-related Kaposi, sarcoma [ J ]. J Clin Pharmacol,1996,36(1) ; 55 -63.
  • 5RIFKIN RM, GREGORY SA, MOHRBACHER AN,ef al. Pegy-lated liposomal doxorubicin, vincris-tine, and dexamethasoneprovide significant reductionin toxicity compared with doxorubi-cin ,vincristine, and dexamethasone in patients with newly diag-nosedmultiple myeloma[ J]. Cancer,2006 ,106(4) ;848 - 858.
  • 6KESTERSON JP,ODUNSI K, LELE S,et al. Highcumulativedoses of pegylated liposomal doxorubicin are notassociated withcardiac toxicity in patients with gynecologicmalignancies [ J ].Chemother, 2010, 56(2) : 108 -111.
  • 7O,BRIEN ME,WIGLER N,INBAR M, et al. Reducedcardio-toxicity and comparable efficacy in a phase III trial ofpegylated li-posomal doxorubicin HCl ( CAELYX/Doxil) versus conventionaldoxorubicin for first-line treatment ofmetastatic breast cancer[ J ].Ann Oncol, 2004,15(3) : 440 -449.
  • 8ANNE M , JEREMY W, MICHAEL L,et al. A phase II nonran-domized open-label study of liposomal daunorubicin ( DaunoX-ome) in advanced soft tissue sarcoma [ J ]. Sarcoma, 2006,1(1):1 -5.
  • 9STATHOPOULOS GP.ANTONIOU D , DIMITROULIS J,et al.Liposomal cisplatin combined with paclitaxel versus cisplatin andpaclitaxel in non-small-cell lung cancer: a randomized phase IIImulticenter trial[ J]. Ann Oncol,2010,21(11) : 2227 -2232.
  • 10BOULIKAS T, MYLONAKIS N,ATHANASIOU A,et al. Lipo-somally-encapsulated cisplatin ( Lipoplatin) plus gemcitabine inNSCLC : preliminary results of a phase II trial and its antiangio-genesis potential[ J]. Clin Oncol, 2008 ,26( 15) :1421 - 1429.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部